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The Impact of Periprocedural Myocardial Infarction on Long-Term Outcomes
After Carotid Artery Stenting
Christopher Metzger1, Robert Hibbard2, Douglas Massop3, Rasesh Shah4, Tift
Mann5, Majdi Ashchi6
1Holston Valley Medical Center, Kingsport, TN; 2Bryan Heart Institute, Lincoln, NE;
3Iowa Clinic, Des Moines, IA; 4Sentara Norfolk, Norfolk, VA; 5Wake Hospital, Wake
Forrest, NC; 6Memorial Medical Center, Jacksonville, FL
Background: Previous studies comparing carotid artery stenting to carotid
endarterectomy have shown an increased risk of periprocedural myocardial (MI)
associated with endarterectomy. While findings from the CREST trial revealed that
periprocedural MI has a lesser effect on health status at 1-year compared with stroke,
other studies have demonstrated a strong correlation between periprocedural MI and
long-term mortality. The impact of periprocedural MI after carotid artery stenting on
both 30-day and 1-year mortality has never been clearly indentified.
Methods: SAPPHIRE Worldwide is a prospective, multicenter, observational study to
evaluate the risk of major adverse events (MI, death and stroke) after carotid stenting
by investigators with varied levels of experience and utilizing a formal training
program.
Results: To date, over 10,000 patients have been enrolled and completed 30 day follow
up. More than 7,600 of these patients have completed 1-year follow up evaluation.
Thirty percent of those enrolled were symptomatic and 46% were age 75 years or older.
Periprocedural MI occurred in 0.6% patients (9 Q-wave, 54 Non-Q wave), and one
additional Q-wave MI occurred between 30 days and 1 year. Of patients who
experienced an MI, 22% resulted in periprocedural death and 36% resulted in death at
1-year follow up.
Conclusion: The incidence of periprocedural MI, although less frequently seen after
stenting than endarterectomy, can result in a high rate of mortality in both in the short
and long term. Identification of patients at high risk for periprocedural cardiovascular
events is an important consideration prior to carotid revascularization.
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The iliac side branch: for all or only the few? - a morphological suitability study
Daphne Pavlidis, Christian Jakobs, Jan Brunkwall, Michael Gawenda
Vascular and Endovascular Surgery, University Hospital Cologne, Cologne,
Germany
Background: Endovascular aneurysm repair for aneurysms extending to the iliac
artery is still a challenge. Interventional occlusion of the hypogastric artery and thus
creating a distal landing zone in the external iliac artery is a common method with
method specific morbidity (buttock claudication, impotence). As alternative iliac side
branched stentgrafts can maintain pelvic blood supply, but the morphological
applicability is limited. Aim of the study was to investigate the morphological
applicability of commercially available iliac side branches (COOK Zenith branched
graft - ZBIS) in our patients’ population with aortoiliac aneurysms.
Methods: A retrospective single-centre study was conducted of 50 patients (45 men;
median age 71.5 years, range 53-90) undergoing repair of aortoiliac aneurysms (open
repair, hypogastric occlusion prior to EVAR and ZBIS) between 2008 and 2010. All
available CT angiograms with post-processing imaging were compared to criteria for
morphological applicability to the (1) manufacturer’s instruction for use (IFU) and to
(2) criteria published by experienced surgeons in the literature as well as to the (3) in-
house institutional protocol of our department.
Results: In 50 patients, 69 targeted iliac aneurysms were studied. Of these, 29/69
(42%) were compliant to the manufacturer’s IFU (1), 25/69 (36%) were compliant to
the published criteria (2), 38/69 (55%) were compliant to the in-house protocol (3).
Most common morphological exclusion criteria were an aneurysmatic hypogastric
artery.
Conclusion: Stent-grafts with an IIA side branch offer an opportunity to repair
aortoiliac aneurysms without sacrificing the hypogastric artery, but not all aneurysms
are morphological suitable. In our patients’ population with aortoiliac aneurysm,
maximum 55% could have been treated with an iliac side branch based on the current
experience. Especially aneurysmatic hypogastric artery and extreme tortuosities of the
iliac arteries seem to be a limiting factor for the use of iliac side branches.
TCT-555
Higher CD34+ Cells Concentration and Lower Degree of Inflammation are
Associated with Better Therapeutic Response to Autologous Bone Marrow Cells
Application in Patients with Critical Limb Ischemia
Juraj Madaric1, 2, Andrej Klepanec1, 2, Marek Toth2, Martin Mistrik3, Martina
Valachovicova1, Ingrid Olejarova2, Roman Necpal2, Rastislav Bazik2, Zoroslav Zita2,
Branislav Liska2, Augustin Mistrik1, 2, Ivan Vulev1, 2
1Slovak Medical University, Bratislava, Slovakia; 2National Cardiovascular
Institute, Bratislava, Slovakia; 3Clinic of Haematology and Transfusiology, Faculty
Hospital, Bratislava, Slovakia
Background: The aim of our study was to analyzed factors associated with the
therapeutic benefit of autologous bone marrow cells (BMC) application in patients
(pts) with critical limb ischemia (CLI).
Methods: Forty-one patients (age 66±10 years, M:F 35:6) with advanced CLI
(Rutherford category 5,6) not eligible for revascularization were randomized to
treatment with 40ml of BMC either using local IM (n=21) or selective IA infusion
(n=20). Primary end points were limb salvage and wound healing. Secondary end
points included changes in transcutaneous oxygen pressure, quality of life questionnaire
(EQ 5D), ankle-brachial index, and pain scale (0-10 scale). Patients with limb salvage
and wound healing were considered as responders to BMC therapy.
Results: At 6-months follow-up, in the entire cohort the limb salvage was 73% (27/37),
four pts died unrelated to stem cells therapy. At univariate analysis, the CD34+ cells
count >20x10^6 was associated with a positive therapeutic response to BMC therapy
(p=0.015, OR 4.7 (95% CI 1.15-19.24)), and peripheral blood leukocytes count
>10x10^9/l was associated with negative therapeutic response (p=0.006, OR 2.1 (95%
CI 1.06-4.1)), as well as CRP level >10mg/l (p=0.038, OR 1.54 (95% CI 1.01-2.32)).
By multivariate analysis the number of administrated CD34+ cells >20x10^6 emerged
as an independent predictor of clinical benefit after BMC application (p=0.03) with
80% specificity and 65% sensitivity. Importantly, there were no differences in IM
versus IA application after 6 months in all observed parameters.
Conclusion: Higher CD34+ cells concentration, and lower degree of inflammation are
associated with better clinical therapeutic response to BMC therapy in pts with CLI.
Both IM and IA cells delivery are effective and comparable therapeutic strategies.
TCT-556
Percutaneous Transluminal Angioplasty of the Subclavian Arteries. Long-term
Follow up
Michel Henry1, 2, Isabelle Henry3, Antonios Polydorou4
1CABINET DE CARDIOLOGIE, Nancy, France; 2Global Reseach Institute,
Hyderabad, India; 3Polyclinique Bois Bernard, Bois Bernard, France; 4Pantaleimon
General Hospital, Athens, Greece
Background: To review feasibility, safety and long-term results of subclavian artery
angioplasty.
Methods: 357 pts (˛:205, mean age:65.2±12 y) underwent percutaneous treatment
for subclavian artery(SA) occlusive disease (stenosis:254, occlusion:92).Left:272,
Right:85, Innominate Artery:18. Etiology: atheromatous:349,others:8 (Takayasu:4)
Mean% stenosis 82.8 ±7.7. Mean lesion length:23.7 ± 8.9mm Indications for treatment
were upper limb ischemia (ULI) (n=167) Vertebrobasilar insufficiency (VBI)
(n=137),associated VBI and ULI (n=103), coronary steal syndrome (n=16)
asymptomatic pts with severe coronary disease (n=53) 29 pts had associated Vertebral
Artery stenosis,71 carotid stenoses,303 lesions were prevertebral,35 post vertebral,
both 19. Percutaneous techniques included retrograde femoral (n=257), brachial artery
(n=71) access or both (n=29) and in 6 cases the “pull through technique”). An isolated
balloon angioplasty was performed in 59 cases and 298 stents were implanted (balloon
expandable:236, self expandable:62.
Results: Technical success was obtained in 339 lesions (95 %) 100% for stenoses.
Only 74 occlusions were recanalized (80 %). Four periprocedural events occurred (1.2
%),1 major (fatal stroke),1 TIA, 2 arterial thromboses. At follow-up (mean follow-
up:68.7 months±37.5),we had 37 restenoses (12 %).13 occurred following angioplasty
alone(18.8 %) and 24 following angioplasty and stent implantation (8.6 %)
(P<0.01).Primary (PI) and secondary (PII) patencies on an intention to treat basis at
10-y follow-up were 79.5% and 85.7% respectively. In pts without initial stent
placement, the rates were 67.5% and 75.5% while in those with stents, the rates rose
to 91.2% and 97.6% (P<0.01).PI for all recanalized lesions were 85.3%, 79.1% without
stent,91.2% with stent (P<0.04) and PII 92.3%,88.5%,97.6% respectively (P<0.02).
Conclusion: P.T.A. is currently the treatment of choice for subclavian artery lesions.
It is a safe and effective procedure associated with low risks and good long-term results.
Stents seem to limit the restenosis rate and improve long-term results
TCT-557
Thoracic abdominal endovascular aneurysm repair (TEVAR) in the
management of Acute Aortic Syndrome (AAS). An early experience with de-
branching, chimney techniques and Multi-Layer stenting
Sherif Sultan1, 2, Peadar Waters1, Niamh Hynes2, 1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Background: 33 TEVAR were performed for 31 patients (13 females: 18 Males) over
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